Over-expression of P-glycoprotein in malformations of cortical development

NeuroReport

Volumn 10, Issue 16, 1999, Pages 3437-3441

  Sisodiya, Sanjay M ^a   Heffernan, Josephine ^b   Squier, Marian V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Drug resistance; Epilepsy; Malformation of cortical development; P glycoprotein

Indexed keywords

ANTICONVULSIVE AGENT; GLYCOPROTEIN P;

ARTICLE; BRAIN MALFORMATION; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; GENE OVEREXPRESSION; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0032693058     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911080-00032     Document Type: Article

References (24)

1. 1. Tishler DM, Weinberg KI, Hinton DR et al. Epilepsia 36,1-6 (1995).
2. 2. D'Giano C, Sevlever G, Lazarowski A et al. Epilepsia 38 (suppl 8), 87 (1997).
3. 3. Schuetz EG, Beck WT and Schuetz JD. Mol Pharmacol 43, 311-318 (1996).
4. 4. Li LM, Fish DR, Sisodiya SM et al. J Neurol Neurosurg Psychiatry 59, 384-387 (1995).
5. 5. de Rijk-van Andel JF, Arts WFM and de Weerd AW. Dev Med Child Neurol 30, 126-127 (1988).
6. 6. Cieuta C, Guerrini R, Ferrari AR, Dulac O. Antiepileptic drug treatment and intractibility of epilepsy related to cortical dysplasia. In: Guerrini R, Andermann F, Canapicchi R et al., eds. Dyplasias of Cerebral Cortex and Epilepsy. Philadelphia: Lippincott-Raven, 1996: 337-344.
7. 7. Raymond AA, Fish DR, Sisodiya SM et al. Brain 116, 629-660 (1995).
8. 8. Georges E, Bradley G, Gariepy J and Ling V. Proc Natl Acad Sci USA 87, 152-156 (1990).
9. 9. Moran E, Larkin A, Doherty G et al. J Clin Pathol 50, 465-471 (1997).
10. 10. Beck WT, Grogan TM, Willman CL el al. Cancer Res 56, 3010-3020 (1996).
11. 11. Rao VV, Anthony DC and Piwnica-Worms D. Cancer Res 54, 1536-1541 (1994).
12. 12. Ling V. Cancer Chemother Pharmacol 40(suppl). S3-S8 (1997).
13. 13. Schinkel AH, Smit JJM, van Tellingen O et al. Cell 77, 491-502 (1994).
14. 14. Levy RH, Mattson RH and Meldrum BS. Antiepileptic Drugs, 4th edn. New York: Raven Press, 1995.
15. 15. Pirker R, Wallner J, Geissler K et al. J Natl Cancer Inst 83, 708-712 (1991).
16. 16. Sato H, Preisler H, Day R et al. Br J Haematol 75, 340-345 (1990).
17. 17. Fardel O, Lecureur V and Guillouzo A. Gen Pharmacol 27, 1383-1291 (1996).
18. 18. Lacueva FJ, Turuel A, Calpēna R et al. Histopathology 32, 328-334 (1998).
19. 19. Thiebaut F, Tsuruo T, Hamada H et al. J Histochem Cytochem 37, 159-164 (1989).
20. 20. Norris MD, Gilbert J, Madafiglio J and Haber M. Gene 156, 313-314 (1995).
21. 21. Lehne G, De Angelis P, Clausen OP et al. Cytometry 20, 228-237 (1995).
22. 22. Shapiro AB, Fox K, Lee P et al. Int J Cancer 76, 857-864 (1998).
23. 23. Matsumoto T, Täni E, Kaba K et al. J Neurosurg 74, 460-466(1991).
24. 24. Begley DJ, Lechardeur D, Chen ZD et al. J Neurochem 57, 988-995 (1996).